Adagio Medical Holdings, Inc. (ADGM) stock
Close on Nov 11, 2026Market cap $41.53MP/E –Yield –
Adagio Medical Holdings, Inc. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$16.57M. At the latest close the market valued the company at $41.53M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $41.53M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -39.90%
Fundamentals
- Revenue
- $0
- Net income
- -$27.14M
- EPS, diluted
- -$1.43
- Free cash flow
- -$16.57M
- Book value per share
- -$0.02
- Diluted shares
- 22M
Trading
- Next earnings
- Nov 11, 2026 (estimated, after the close)
- Previous close
- $1.84
- Open
- $1.84
- Day's range
- $1.61 – $1.87
- Volume
- 52,494
- Average volume (20 days)
- 1,384,960
- 52-week range
- $0.08 – $50.71
- RSI (14 days)
- 46.9
- Volatility (1 year)
- 16699.0%
- Relative volume
- 0.04×
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ADGM | S&P 500 | Difference | ADGM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -52.1% | -2.4% | −49.6 pts | ||
| 3 months | -91.3% | -1.2% | −90.2 pts | ||
| Year to date | -94.0% | +12.3% | −106.3 pts | ||
| 1 year | +114.4% | +12.4% | +101.9 pts | ||
| 3 years | -99.4% | +78.8% | −178.2 pts | -82.1% | +21.4% |
| 5 years | -99.4% | +75.2% | −174.5 pts | -63.8% | +11.9% |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Adagio Medical filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Results
- News
- Results
- News
About Adagio Medical
Surgical & Medical Instruments & Apparatus
Adagio Medical is a medical device company that develops and commercializes catheter-based systems for treating cardiac arrhythmias, focusing primarily on ventricular tachycardia. Its core offerings include the vCLAS Cryoablation System and Ultra-Low Temperature Ablation console, which use pressurized, near-critical liquid nitrogen to create deep, durable lesions in cardiac tissue without fluid irrigation. The company also develops pulsed field cryoablation technologies combining ultracold cryoablation with pulsed field energy. These medical solutions are designed for electrophysiologists, cardiac catheterization laboratories, and hospital ablation centers treating patients affected by ventricular tachycardia, structural heart disease, and atrial fibrillation.
Company profile, executives and historyAdagio Medical stock: common questions
What is Adagio Medical's stock price?
ADGM closed at $1.87 on Nov 11, 2026, up 1.63% on the day. Over the past 52 weeks it traded between $0.08 and $50.71.
What is Adagio Medical's market cap?
Adagio Medical was worth $41.53M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ADGM's P/E ratio?
Adagio Medical lost money over the twelve months to Jun 30, 2026 (diluted EPS -$1.43), so it has no meaningful P/E ratio.
How much revenue does Adagio Medical make?
Adagio Medical reported revenue of $0 for the twelve months to Jun 30, 2026.
Does Adagio Medical pay a dividend?
No. Adagio Medical has not paid a cash dividend over the last twelve months.
When does Adagio Medical report earnings next?
Adagio Medical is expected to report Q3 FY2026 results on Nov 11, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has ADGM stock performed over the past year?
Including dividends, ADGM returned +114.4% over the past year, against +12.4% for the S&P 500.
How many ADGM shares are sold short?
0M shares were sold short at the latest FINRA report, 1.29% of the float, or 1.0 days of average trading volume.
Who are Adagio Medical's competitors?
Companies most similar to Adagio Medical by business, industry and size include ATRC, PLSE, CVRX, OBIO, ANGO.
See a number that looks wrong?